STOCK TITAN

APLS shareholder plans 1,334-share Rule 144 sale after vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An APLS shareholder filed a notice of intent under Rule 144 to sell 1,334 common shares through Fidelity Brokerage Services LLC on 01/20/2026 on NASDAQ, with an aggregate market value of 26,403.73. These shares were acquired on 01/16/2026 via restricted stock vesting from the issuer as compensation, with payment also dated 01/16/2026.

Over the prior three months, Mark J. Delong sold 1,780 common shares on 01/13/2026 for gross proceeds of 39,493.22. By signing the notice, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the APLS Form 144 filing disclose?

The Form 144 discloses that an APLS shareholder intends to sell 1,334 common shares on 01/20/2026 on NASDAQ through Fidelity Brokerage Services LLC.

How many APLS shares are covered by this planned Rule 144 sale?

The planned sale covers 1,334 common shares of APLS, with an aggregate market value reported as 26,403.73.

How were the APLS shares being sold under Form 144 acquired?

The 1,334 common shares were acquired on 01/16/2026 through restricted stock vesting from the issuer as compensation.

What prior APLS share sales by this person are disclosed?

The filing reports that Mark J. Delong sold 1,780 common shares on 01/13/2026 for gross proceeds of 39,493.22 during the past three months.

How many APLS shares are outstanding according to this filing?

The filing lists 126,525,218 common shares as the number of APLS shares outstanding.

Which broker is handling the planned APLS Form 144 sale?

The planned sale of 1,334 common shares is listed with Fidelity Brokerage Services LLC, based in Smithfield, Rhode Island.

Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.59B
106.56M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM